BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38532486)

  • 1. Cognitive decline, Aβ pathology, and blood-brain barrier function in aged 5xFAD mice.
    Nehra G; Promsan S; Yubolphan R; Chumboatong W; Vivithanaporn P; Maloney BJ; Lungkaphin A; Bauer B; Hartz AMS
    Fluids Barriers CNS; 2024 Mar; 21(1):29. PubMed ID: 38532486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
    Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
    Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
    Devi L; Ohno M
    Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
    Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer's Disease.
    Migliorati M; Manrique C; Rahrah M; Escoffier G; El Ahmadi A; Girard SD; Khrestchatisky M; Rivera S; Baranger K; Roman FS
    J Alzheimers Dis; 2022; 90(1):251-262. PubMed ID: 36093693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
    Zhou R; Chen LL; Yang H; Li L; Liu J; Chen L; Hong WJ; Wang CG; Ma JJ; Huang J; Zhou XF; Liu D; Zhou HD
    Curr Alzheimer Res; 2021; 18(5):428-442. PubMed ID: 34488598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice.
    Vilella A; Bodria M; Papotti B; Zanotti I; Zimetti F; Remaggi G; Elviri L; Potì F; Ferri N; Lupo MG; Panighel G; Daini E; Vandini E; Zoli M; Giuliani D; Bernini F
    Brain Behav Immun; 2024 Jan; 115():517-534. PubMed ID: 37967665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathology.
    Gnoth K; Piechotta A; Kleinschmidt M; Konrath S; Schenk M; Taudte N; Ramsbeck D; Rieckmann V; Geissler S; Eichentopf R; Barendrecht S; Hartlage-Rübsamen M; Demuth HU; Roßner S; Cynis H; Rahfeld JU; Schilling S
    Alzheimers Res Ther; 2020 Nov; 12(1):149. PubMed ID: 33189132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
    Devi L; Ohno M
    Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centella asiatica attenuates hippocampal mitochondrial dysfunction and improves memory and executive function in β-amyloid overexpressing mice.
    Gray NE; Zweig JA; Caruso M; Zhu JY; Wright KM; Quinn JF; Soumyanath A
    Mol Cell Neurosci; 2018 Dec; 93():1-9. PubMed ID: 30253196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aβ reduction in BACE1 heterozygous null 5XFAD mice is associated with transgenic APP level.
    Sadleir KR; Eimer WA; Cole SL; Vassar R
    Mol Neurodegener; 2015 Jan; 10():1. PubMed ID: 25567526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral microvascular rather than parenchymal amyloid-β protein pathology promotes early cognitive impairment in transgenic mice.
    Xu W; Xu F; Anderson ME; Kotarba AE; Davis J; Robinson JK; Van Nostrand WE
    J Alzheimers Dis; 2014; 38(3):621-32. PubMed ID: 24037035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of amyloid-beta levels in mouse eye tissues by intra-vitreally delivered neprilysin.
    Parthasarathy R; Chow KM; Derafshi Z; Fautsch MP; Hetling JR; Rodgers DW; Hersh LB; Pepperberg DR
    Exp Eye Res; 2015 Sep; 138():134-44. PubMed ID: 26142956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive benefits of memantine in Alzheimer's 5XFAD model mice decline during advanced disease stages.
    Devi L; Ohno M
    Pharmacol Biochem Behav; 2016 May; 144():60-6. PubMed ID: 26948858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.
    Nakagawa T; Hasegawa Y; Uekawa K; Kim-Mitsuyama S
    Exp Gerontol; 2017 Jan; 87(Pt A):108-112. PubMed ID: 27916702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vortioxetine administration attenuates cognitive and synaptic deficits in 5×FAD mice.
    Jiang LX; Huang GD; Su F; Wang H; Zhang C; Yu X
    Psychopharmacology (Berl); 2020 Apr; 237(4):1233-1243. PubMed ID: 31953648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.